 |
| Author | Post |
|---|
sunflower
Guests visiting Phase 1/2/3
|
Posted: Wed Aug 6th, 2008 08:08 |
|
| i don't know if this is the right place to post this, but i found this article very interesting: http://advanceindiana.blogspot.com/2008/08/have-health-experts-been-wrong-about.html sun
____________________
lyme,fibro,candida,allergies,gerd,osteopenia/ pain,fatigue,dizzy,memoryloss20+yrs/ celexa,vicodin,cal-mag/beni 40mg q6h 11-05/phase 3,8-06/1,25d=34 25d=36,18,17,10,13,5,7
|
Dr Trevor Marshall
Foundation Staff
|
Posted: Wed Aug 6th, 2008 08:46 |
|
Sun,
This is not really a good place to discuss this topic. It is a complex one, which we explored at our LAX 2006 conference with Dr Alan Cantwell, one of the most controversial figures in the AIDS debate.
It is not a good time to discuss this as Science is right in the middle of a number of discoveries which will change the way that all infectious diseases are seen in isolation, assumed to be caused by one pathogen, and nothing else. This concept dates back to the Postulates of Koch, and is 19th century thinking.
What I will say is that even the conspiracy theorists don't understand the complexities of what they are playing with. I want to direct you to one paper. Knowing what you all know about the VDR, you can understand what would happen if somehow the VDRs that Benicar is activating were to be co-opted by a virus, and no longer be available to drive your immune function. That is exactly what the HIV virus does.
http://jme.endocrinology-journals.org/cgi/content/full/38/6/587"Our data show VDR-dependent activation of the HIV-1 LTR in this cell type, supporting a possible role for this receptor in HIV-LTR-mediated transactivation and therefore on the progress of AIDS."
..
"In conclusion, our data point to the importance of VDR signaling in HIV transactivation, which can occur through ‘classical’ and ‘non-classical’ mechanisms."
It turns out that the active phase of HIV infection co-opts the VDR,without the need for 1,25-D activation, as part of its own replication, obviously leaving the patient immuno-compromized. From that point on, IMO, everything just slides slowly downhill through all the Th1 diseases which occur during the chronic phase of AIDS.
As we get the word out about our own work, at that point we can start to help the HIV researchers. At this point even the researchers who did that study I cited, apparently have no idea of the implications of what they have found...
My own wild guess is that the surge in AIDS incidence might well be found to coincide with the surge in Th1 disease, as Th1 weakened innate immune systems would be unable to deal with the assault of HIV...
Trevor
|
migsies
Member in Phase 3
|
Posted: Thu Aug 7th, 2008 02:59 |
|
Interesting post Sun! I am not too surprised by these researacher's findings and I am pleased to see them focus on the role of the VDR in HIV. Perhaps Dr. Marshall's work on the role of innate immunity in disease is finally having some impact on research priorities. I certainly hope so.
Maybe with time we will discover that some aspects of their model of VDR dependent viral reactivation extends to a number of other viral entities, including the plethora of herpes viruses. Such a model would be consistent with the experience that some people have with herpes reactivation in response to immune activity and/or solar exposure (once immunosuppression from the initial D25 surge declines and the D1,25 is able to work on the VDR). I suppose one would expect strong positive selection for the expression and survival of any virus that can dissable innate immunity (hence apoptosis), by linking itself to the VDR or associated genes or other yet undetermined mechanism. It seems to me that this type of infection would put the host in the pardoxical situation of having to "decide" between a downregulated immune state that predisposes to an assortment of secondary/opportunistic intracellular infections, and an innate immune activation that might offer short term protection but is linked to the expression of a viral antigen hence the ravages of chronic inflammation. In the long term, as the body struggles to find balance, one might predict ongoing cellular damage (including mitochondrial damage) and a decline in innate immune function. At some point, this process might manifest as an increased Th1 response reflecting a compensatory attempt by the host to control the levels of intracellular infection in the face of declining innate immune function. Sound familiar? Of course, as we all know from Dr. Marshalls work, a hyperactvie Th1 response is fraught with problems too.
Maybe the factors that determine whether one gets over an initial viral infection or progresses to chronic illnesses such as CFS include not only familial clustering and exposure to pathogens (epidemiological factors) but also the chance event that viral insertion and/or reactivation (inherited viral gene components) occurs in association with genes involved in innate immunity and apoptosis. As they say on HGTV...location, location, location. This mixture of stochasticity and epidemiological pattern, not to mention our modern day "genetics" based medical paradigm, might explain why researchers have been so befuddled, looking for elusive pattern and endlessly debating whether these chronic illnesses are of genetic or infectious origin. Ignorance of L-forms is probably another factor. IMO, pattern can usually only be teased appart from randomness if one has a good hypothesis that includes at least key components of the underlying mechanism.
In all fairness, I do not mean to favor a viral hypothesis of chronic illness and underestimate the role of L-forms in initiating or perpetuating the kind of inflammation and cellular damage that could ultimately lead to innate immune system decline and viral reactivations. This would be overly simplistic and besides, I am personally not attached to any particular dogma, I am only interested in explanations that adequately explain the phenomena in question or provide good clinical outcomes. IMO, we are dealing with a very complex set of factors and it seems to me that once cellular infection is set into motion it becomes almost impossible and counterproductive to assess blame. For the record, I strongly support Dr. Marshall's attempts to get at the problem of innate immunity from the angle of the VDR as this is the most expeditious approach. I just hope that this HIV study doesn't add a new wrinkle, a new and potentially frustrating layer of complexity. The implications are certainly troubling.
Anyway, it is the interplay between these viral pathogens and the L-forms, and the way they jointly modulate innate immunity, that raises all the interesting and relevant questions for me. How I wish that the relationship between infection and innate immunity were a primary focus of NIH funding, as I am certain that therein lies not only a better understanding of chronic illness but perhaps also the prevention of innate immune related diseases prevously thought to be inevitable, such as cancer. I am glad that Dr. Marshall has been hot on this trail, offering up some answers, treatment, and drawing attention to the importance of the intracellular microbial millieu to innate immunity and disease in general.
Thank you Sun for the interesting link!
____________________
Sarcoidosis FM Lyme babesia 25D>7(Feb07) Ph1Aug05 Ph2Oct05 Ph3 Jun06 Valium Lyrica Ambien NoIRs limited outings covered Phase I 8/05, II 10/05, III 6/06.
|
eClaire
Member in Phase 2
| Joined: | Mon Sep 25th, 2006 |
| Location: | Virginia USA |
| Posts: | 859 |
| Status: |
Offline
|
|
Posted: Fri Aug 8th, 2008 07:53 |
|
When my brother was diagnosed with AIDS, he recovered from the brink of death from pneumonia and was put on AZT and given two years to live. As those two years drew to a close, he appeared to be just weeks from death. Then the AIDS cocktail was approved for wide-scale use, and he went on to live another 8.5 years. I have no doubt that the AZT contributed to his declining health, and who knows the affect of the other drugs? I did see the side affects, however, and they were horrendous, causing him at times to give up the drugs until his doctor would switch the combination (essentially he would go on a medicine strike).
Except for pneumonia one other time, my brother continued to be someone who rarely caught a virus and never had a cold (much like me) although that is what was predicted by his doctors (he eventually stopped taking precautions around sick people because he seemed impervious to other viruses). Eventually, he suffered from congestive heart failure. (This is the fate I believe I was headed toward if not for the MP.)
One thing that my brother said when he was first diagnosed that has always stuck in my mind is that he now understood what I had been going through (this was before my CFS diagnosis but not before I had nearly all of the symptoms attributed to that label), as our illnesses seemed nearly idential to him. Indeed, in the couple years before being diagnosed with AIDS he had started to become sensitive to formaldehyde.
I am hopeful that AIDS will one day be better understood and that the work of Dr. Marshall will one day help people with an AIDS diagnosis just like it is helping so many other people.
Claire
____________________
38mo on MP; CFS FMS MCS COPD hypermob. IBS/GERD osteopor.; 125D48 25D<4;
NoIRs during most daylight outings & covered up; home w/o NoIRs
Ph1.Dec06 * ModPh2.Jun07 * AbxBrk.Mar-May08 * Ph2.Oct-Nov08 * Ph1.Jan2009
|
jamesnfl
Member in Phase 3
|
Posted: Sat Jun 6th, 2009 17:22 |
|
Firstly, I would like to wish a hearty welcome home to Trevor and Amy!! After I watched the presentations from Prague I have a couple of questions for Trevor. Even though I began the MP due to the autoimmune connection with Vitiligo that "came out of the blue" and was unresponsive to conventional therapy. I have never really understood the correlation between the MP and HIV, In the early MP DVDs, Dr Alan Cantwell makes the point that an opportunistic type of cancer connected with advanced HIV disease, Kaposi Sarcoma was found to be TH1 disease related. Now in the the Prague presentations, Trevor spoke about how the VDR is an important component of how HIV is able to survive and thrive. Trevor would you please comment on what you feel the direct/indirect effect the MP actually has on HIV and the course of the illness? Also, since HIV is actually a retrovirus (making the HIV antibodies that the body produces,ineffective at "neutralizing" the pathogen)rather than a virus such as influenza, how does the MP help the body fight retroviruses?
Even thought the antiretroviral medications do have a lot of side effects,most of my contemporaries who became ill prior to the antiretroviral meds have LONG since moved on "beyond the veil". I do contribute my 20+ years survival at least in part to the meds.
Trevor would you please comment on your quote from the Prague presentation concerning antivirals medications. Do you feel the same about antiRETROviral medications? Thank you in advance for your perspective!!
____________________
HIV+ 21yrs... extreme fatigue vitiligo changes in skin tone/texture hx cardiomyopathy 125D59 25D 48; Aug08 25D=8;25D Aug 09=7;Ph1Apr08 Coreg, Truvada, Reyataz, NoIRs in & out
|
jamesnfl
Member in Phase 3
|
Posted: Sat Jun 6th, 2009 17:38 |
|
Page 12 of the transcript from the Prague second session deals with a question posed to you about Antivirals. I can't seem to be able to copy and paste. Bu tyou seem to be against them.Please comment.
____________________
HIV+ 21yrs... extreme fatigue vitiligo changes in skin tone/texture hx cardiomyopathy 125D59 25D 48; Aug08 25D=8;25D Aug 09=7;Ph1Apr08 Coreg, Truvada, Reyataz, NoIRs in & out
|
Dr Trevor Marshall
Foundation Staff
|
Posted: Sat Jun 6th, 2009 18:20 |
|
James,
The anti-retroviral cocktails which have managed to control HIV, and lengthen the lives of so many victims, are very effective. They invariably take the HIV count from high levels to low levels.
But that is (IMO) where discovery has stalled. There are few solutions available to deal with the decade(s) of the chronic phase of AIDS, and little understanding about what is happening.
The study which showed how HIV hijacks the VDR should lead to breakthroughs in understanding the chronic phase of AIDS, once scientists become adjusted to the importance of the VDR in the immune system.
One of my colleagues at Murdoch, from the very earliest days of my clinical research in the 1970s, is Simon Mallal, and I have been writing to him periodically as the science has evolved. He is in an ideal position to make sure that the HIV / VDR relationships are followed up:
http://tinyurl.com/nbg9na
|
jamesnfl
Member in Phase 3
|
Posted: Sun Jan 3rd, 2010 15:06 |
|
Happy New Year Trevor !!
I must admit that I am confused about whether you are still advocating the various antibiotic combinations along with the Benicar.
There are references on the website to the fact that the Benicar is "more important" than the antibiotics. I've got that. I get the impression that the site advocates' positions are "well if you don't want to take the antibiotics....you no longer have to".
When the protocol was updated recently, there was a new 11 page Phase 1 document, but nothing addressing Phases 2 and 3, which deal with the antibiotic combinations. I just don't think that this change has been made very clear, at least not to me.
What IS your official position on this? Is it better to go through the 3-5 years of rotating the various antibiotic combinations along with Benicar? Or is the use of them obsolete?
If the treatment is just as effective using only Benicar, why go to the expense and tedious tracking of ramping up and down and around.. the antibiotics? Can one expect a better outcome with or without the abx? Thanks for your time and Best Wishes !!
____________________
HIV+ 21yrs... extreme fatigue vitiligo changes in skin tone/texture hx cardiomyopathy 125D59 25D 48; Aug08 25D=8;25D Aug 09=7;Ph1Apr08 Coreg, Truvada, Reyataz, NoIRs in & out
|
Dr Trevor Marshall
Foundation Staff
|
Posted: Mon Jan 4th, 2010 04:14 |
|
James,
Over the last two years we have had an explosion in understanding of the science which explains why the MP works, and works so well (if a little slower than we would like )
So my focus has shifted from a "take this pill, then that pill" to a "this is how it works - if you need to modify something a little to make your recovery more tolerable, then feel free to do that." Of course, I would still suggest you bounce radical ideas off the moderators and other members first
The best way to find out what has changed is to watch the three most recent YouTube conference presentations:
http://www.youtube.com/watch?v=hcAVeKobsxU
http://www.youtube.com/watch?v=y8AfUg3aJVk
http://www.youtube.com/watch?v=SGe9UTQJdHM
and read the recent papers from my colleagues:
http://autoimmunityResearch.org/preprints/BlaneyAnnals2009Preprint.pdf
http://autoimmunityResearch.org/preprints/ProalAnnals2009Preprint.pdf
http://autoimmunityResearch.org/preprints/WaterhouseAnnals2009Preprint.pdf
http://AutoimmunityResearch.org/preprints/AR-Proal-Metagenome.pdf
http://AutoimmunityResearch.org/preprints/AR-Albert-VitD.pdf
http://www.townsendletter.com/Jan2009/vitaminD0109.htm
http://TrevorMarshall.com/BioEssays-Feb08-Marshall-Preprint.pdf
http://www.aacijournal.com/content/5/1/8/comments#384657
http://www.futuremedicine.com/doi/pdf/10.2217/17410541.6.2.143
The Phase 2/3 guidance hasn't been changed as most of the folk who have transitioned to Phase 2/3 recently have done it with the help of the members and moderators. I will integrate the document into the Phase 1 guideline sometime soon. Maybe even this week, it depends on how much spare time I get
The immune system, once reactivated by Olmesartan, does all the work, the antibiotics help it work more quickly. Please spend the time to listen to the YouTube presentations, and hopefully you will be able to plan your own progress too.
Happy New year,
Trevor
|
sdcreacy
Member in Phase 3
|
Posted: Thu Jan 7th, 2010 16:46 |
|
regarding HIV+
Dr. Marshall,
First, I want to say how much I appreciate the MP. Both my father and myself are making great progress on it. I am excited about it and telling everyone I know.
My question: I have an HIV+ friend who is a 51 yo male disabled by raging osteoporosis. Besides all the usual drugs and bone-building Rx's, his doctors are giving this poor guy HUGE amounts of VitD- something like 15 - 50,000 iu per week!
You've mentioned elsewhere that at the endpoint of AIDS the 1,25D level can drop to below detectable, but I don't think he is there. I have urged him to insist upon a 1,25 test so his doctors will have to confront the idea that he may not be VitD deficient.
I know that your protocol is still young with respect to HIV+ patients, but can you point me to some info/resources or participants who can help me advise my friend better?
Thanks again for all of your great work!
Steve
|
Dr Trevor Marshall
Foundation Staff
|
Posted: Fri Jan 8th, 2010 15:13 |
|
Steve,
I have generally stayed away from talking about treating AIDS, confining my discussions to my colleagues at Murdoch, who are leading WHO-affiliated AIDS researchers.
I have generally been unable to communicate the underlying molecular biology with them. Their expertise is grounded in immunology, not in 21st Century translational medicine. The concept of disease models is not easily grasped. The dream of a vaccine is overpowering and all-consuming.
As much as I would like to help folk suffering from AIDS, I just don't feel the struggle will be fruitful at this point in time. Maybe in a year or two, but not now. The interventions with the potential to reverse the disease process involve not just removing Vitamin D, but a complex of actions, each of which conventional medicine currently regards as 'risky.' The patient would be spending a significant part of his/her available energies educating (and cajoling) their physicians. Once we get a few basic notions more firmly accepted - the actions of Benicar - the actions of Vit D - then the remaining steps will become more palatable to physicians, and seen as less 'risky'.
If your friend was at an early stage of the chronic phase of the disease, without all the drugs you mention, then maybe he would have a chance. But right now he is totally at the mercy of conventional knowledge, I am afraid 
|
Frans
Member in Phase 2
|
Posted: Fri Jan 8th, 2010 15:29 |
|
Trevor,
This reminds me of a question that has been in my mind for some time now.
Have you looked at the affinity of HIV for the VDR ? I was wondering if Beni could/would be potent enough to displace HIV from the VDR ?
Best, Frans
____________________
Burn-out/nervous breakdown Jan01 125D 48 25D8.48 Ph1Nov06 ModPh2Jan07 Ph2Apr08 Cipramil Seroquel NoIRs lite exp r/t work cover up 25D3.9(Oct07)
|
Dr Trevor Marshall
Foundation Staff
|
Posted: Fri Jan 8th, 2010 16:14 |
|
I suspect that HIV-tat positions itself on the outside of the VDR in the location normally occupied by the co-activator. Thus, whether the receptor is liganded may be of secondary importance. That is indeed what the study reporting the HIV-tat VDR activity actually found.
Having said that, Benicar is obviously important in activating those VDR which are not co-opted by HIV, which is generally at a low level during the chronic phase of the disease.
Last edited on Fri Jan 8th, 2010 16:15 by Dr Trevor Marshall
|
Current time is 19:08 | |
|
|
|
|
